Humana Wegovy Prior Authorization: 2026 Rules by Plan

A Humana Wegovy prior authorization is not one process. It can mean basic Part D, a supplemental Medicare benefit, the federal Medicare GLP-1 Bridge, Medicaid, or TRICARE. Which set of rules applies to you depends on two things: what your Humana card says, and why your doctor prescribed Wegovy. Get those two right and the rest is paperwork. Get them wrong and you lose weeks.

That's the part nobody tells you at the pharmacy counter.

Here's what's actually happening. Basic Medicare Part D cannot pay for a drug when it is used only for weight loss. But some enhanced or employer/union Medicare drug plans can add weight-loss drugs as a supplemental benefit. The federal Medicare GLP-1 Bridge is a separate path where Medicare writes the rules and Humana acts as the national processor. If you have Humana Medicaid, your state wrote the criteria. If your card says Humana Military, Express Scripts handles the pharmacy paperwork for the Department of Defense.

We opened all of it. Humana's own 2026 drug list. Humana's own Wegovy prior authorization form for one of its Medicaid states. A state Medicaid criteria document. Medicare's rules, updated two days before we published this. Then we put the numbers side by side, because the rules are easy to mix up.

One number to hold onto: for the same drug, in 2026, behind plans carrying the Humana name, the published BMI thresholds we verified run from 27 to above 40. That is at least a thirteen-point spread. Same medicine. Different rulebook. We'll show you exactly where each number comes from and which one applies to you.

Is this page for you?

Yes, if:

• The pharmacy said Wegovy "needs prior authorization" and stopped there
• Your doctor's office says they submitted something, and nothing has happened
• You got a denial letter and don't know if it's fixable
• Your refill suddenly stopped working
• You want to know exactly which form your doctor should be filling out

No, if:

• You want to know whether Wegovy is right for you medically — that's a conversation with your doctor
• You're comparing telehealth programs → start with Find My GLP-1 Path
• You want compounded semaglutide. Compounded semaglutide is not FDA-approved Wegovy, and a Wegovy prior authorization does not apply to it

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

Does Humana require prior authorization for Wegovy?

Usually, yes, when your exact plan can cover Wegovy. But first you need to know whether the request is a standard prior authorization, a formulary exception, a supplemental-benefit request, a Bridge authorization, or a state Medicaid request. Those are not interchangeable.

Prior authorization just means somebody has to approve the prescription before insurance pays. Nobody argues about that part.

The argument is about who. And that's where people lose a month.

The five systems that can sit behind a Humana card

There is no regular employer-commercial row in that table. Humana announced in 2023 that it was leaving the employer group commercial medical-products business and planned to phase it out over 18 to 24 months. Old commercial criteria still surface in search, so your current card and plan documents matter more than an old article.

One more thing that surprises people: the Bridge uses Humana as Medicare's national processor. That means a Bridge notice can come from Humana even when another company runs your Part D plan. Same processor, completely different rulebook.

### 👉 Not sure which one you're in? Answer five quick questions. We'll tell you which system governs your Wegovy request, which form your doctor needs, what has to be on it, and what your deadline is. Find my Humana Wegovy path → Free. About two minutes. No sign-up, and we never ask for your member ID, Medicare number, or date of birth.

Which Humana plan do you actually have?

Your member card, Evidence of Coverage, and Prescription Drug Guide decide this — not the Humana logo by itself. A card from a current or former employer may be Group Medicare, an employer/union plan with supplemental drug coverage, or another arrangement with a separate pharmacy benefit manager. Do not guess from the company name.

This matters more than it sounds like it should.

Here's the annoying part

Search "Humana Wegovy prior authorization" and much of what comes back explains "Humana's commercial formulary criteria" or "Humana employer plan requirements." Detailed. Confident. Written with review dates on them.

Humana announced it was exiting that business on February 23, 2023. In Humana's own words, the exit covered "all fully insured, self-funded and Federal Employee Health Benefit medical plans." Its stated plan was to phase the business out over 18 to 24 months and focus primarily on government-funded programs and specialty benefits.

So if you followed one of those pages and made a list of requirements, there's a real chance you spent an afternoon studying rules for insurance you don't have.

That's not your fault. It's why we start with your card instead of with criteria.

The Humana product lines that matter here in 2026

Straight from Humana's current product and member pages:

• Medicare Advantage plans, with or without drug coverage
• Standalone Part D drug plans
• Group Medicare — retiree Medicare coverage arranged through an employer or union
• Medicare Supplement plans — current Medigap policies do not include Part D outpatient drug coverage
• Humana Healthy Horizons Medicaid member programs in Florida, Indiana, Kentucky, Louisiana, Ohio, Oklahoma, South Carolina, and Virginia
• TRICARE East, administered through Humana Military, with the pharmacy benefit run by Express Scripts
• Dental, vision, and life insurance

Regular employer group commercial medical coverage was the business Humana announced it was leaving. If your Humana card came from work, look for the words "Medicare," "Group Medicare," "EGWP," or the name of a separate pharmacy benefit manager. Then call the number on the back of the card and ask what kind of drug benefit you have.

Card decoder

Why doesn't basic Humana Medicare Part D cover Wegovy for weight loss?

Federal Part D rules exclude drugs when they are used only for weight loss. That's not Humana's decision, and an appeal cannot turn an excluded basic benefit into a covered one. But some enhanced or employer/union Part D plans can add weight-loss drugs as a supplemental benefit, so check your exact plan before accepting an absolute no.

This is the single most misunderstood thing on the whole topic.

If your prescription says "weight management" and your Humana plan offers only the basic Part D benefit, there is no basic Part D prior authorization to win. Not a hard one. Not a strict one. The use is outside the basic benefit.

But do not stop there until you ask one more question: "Does my exact plan add anti-obesity drugs as a supplemental excluded-drug benefit?" CMS allows some enhanced and employer/union Part D plans to do that. If the answer is no, the federal Bridge may be the weight-management door.

There's a different door. We'll get to it.

What Humana's own 2026 drug list shows — and what it does not

We opened Humana's 2026 Group Medicare Commonly Prescribed Medications List — the Group Plus Formulary, Formulary ID 26800 — and read it front to back on August 8, 2026.

It has 18 drug categories. Antidepressants, antipsychotics, anxiety, asthma, blood thinners, diabetes pills, diabetes injections, eye drops, gout, blood pressure, cholesterol, hormones, neurological, pain, heartburn, sleep, thyroid, urinary.

There is no weight-loss category. Not an empty one. The category isn't in the document.

Meanwhile the two diabetes categories contain several GLP-1 products.

Ozempic, Rybelsus, and Wegovy all contain semaglutide, even though this incomplete summary names only Rybelsus. That does not make their coverage interchangeable. The active ingredient alone does not decide coverage. The product, FDA-approved use, stated purpose, and exact plan all matter.

Honest limits on that finding: this is one Humana summary list out of several, and the document says so itself — "This is not a complete list." Your own plan's Prescription Drug Guide and Evidence of Coverage are the final word. The list is useful for seeing how Humana handles named diabetes drugs. It is not enough to prove what your exact plan does with Wegovy.

The two basic Part D uses that can be open for Wegovy

Wegovy has FDA-approved uses that can fall inside basic Part D because they are not weight loss alone:

1. Reducing the risk of heart attack, stroke, and cardiovascular death in adults who already have cardiovascular disease and are overweight or have obesity.
2. Treating noncirrhotic MASH with moderate-to-advanced liver scarring in adults. Injection only — the tablets do not carry the MASH indication.

Your exact Humana plan can still require prior authorization or a formulary exception. A Part D-coverable use does not guarantee that Wegovy is on the formulary.

There may also be a third Medicare lane: supplemental weight-management coverage added by an enhanced or employer/union plan. That is not one national rule. Your EOC, PDG, and supplemental drug list control it.

What does each Humana Wegovy prior authorization actually require?

The requirements are not similar between systems — they're wildly different. The federal Bridge uses your BMI from when you first started GLP-1 treatment and publishes no step-therapy requirement. One Humana Medicaid form requires a BMI above 40 and proof you already failed a different weight-loss drug. A state Medicaid document requires you to be 45 or older for its heart-risk path. We put them side by side so you can see why the same request can pass in one system and fail in another.

This is the table we built this page for.

Every detailed column is a real document. We opened each one on August 8, 2026, and the date or version is named below. We left the Humana basic Part D column thin where Humana's public summary did not publish the clinical rule. We will not fill a blank with a guess.

The Humana Wegovy Prior Authorization Comparison — v1.1, verified August 8, 2026

A supplemental Humana Medicare weight-management benefit is not in the table because there is no single public rule to compare. One employer/union plan can set different criteria from another. Pull your exact EOC, PDG, and supplemental drug list.

Four things in that table that will change what you do

1. The published BMI range behind the Humana name starts at 27 and runs above 40.

Louisiana's cardiovascular path starts at a BMI of 27 — but only with the rest of that path, including age 45 or older and established cardiovascular disease. Humana's own Virginia Medicaid form needs a BMI over 40 without a listed risk factor. The federal Bridge can start at 27 only with one of its listed conditions.

If your BMI is 33, you may qualify for the Bridge at $50 a month and still be more than seven points short of Humana's Virginia Medicaid weight-management rule. Same drug. Same year. Same brand on the card.

2. On the Virginia form, "failed" has a number attached to it.

Most pages say "step therapy may apply" and leave it there. Humana's Virginia form publishes exactly what counts as a failed trial:

The stimulant and orlistat rows can satisfy the separate non-GLP-1 requirement. The GLP-1 row applies when the preferred drug list also requires a trial of another GLP-1; it does not replace the non-GLP-1 rule.

That's not a vague hurdle. That's a checklist. If you've already tried phentermine and it didn't work, the dates and the pound count matter, and your doctor needs them from your chart.

3. Losing enough weight can eventually end Virginia coverage.

Humana's Virginia form says renewals "will no longer be granted once a member reaches a BMI < 25." And the renewal test measures 5% loss against your most recent authorization — not your original starting weight. So every six months, the form asks for another 5% against the last authorization point.

Read those two rules together and you get an odd result: the treatment working well can eventually end the approval.

4. A diabetes diagnosis can hurt you here, not help you.

We need to be direct about this because there's bad advice circulating.

Some pages tell readers to have their doctor put a type 2 diabetes code on a Wegovy request to get it approved. Don't.

• Wegovy is not FDA-approved to treat diabetes. The current TRICARE form says non-FDA-approved uses are not approved and names diabetes mellitus.
• Type 2 diabetes makes you ineligible for the federal Bridge.
• Louisiana's cardiovascular criteria require that you do not have type 1 or type 2 diabetes.

So that "workaround" can close real doors. What actually helps is documenting accurately what's already in your chart. Asking for a diagnosis or purpose you do not have puts you and your doctor at risk and makes the request less defensible, not more.

### 👉 Print the packet your doctor needs One page, matched to your system: the exact criteria list, what has to be documented, the dates and numbers reviewers look for, and where to send it. Get my printable prescriber checklist → Free, no email required. It's a list of questions and records to review with your prescriber — not a completed authorization form.

Is the Medicare GLP-1 Bridge the same as Humana's prior authorization?

No, and this trips up nearly everyone. Medicare uses Humana as the national Bridge processor, so the processor is the same no matter which eligible company runs your Part D plan. But Medicare writes the Bridge rules, your plan does not have to opt in, the copay is a flat $50 per monthly supply, and there is no formal appeal — only resubmission when information is corrected, added, or updated.

The Medicare GLP-1 Bridge is a temporary federal program running July 1, 2026 through December 31, 2027. It operates outside Part D. CMS created it as a separate demonstration while basic Part D still excludes drugs used only for weight loss.

CMS is using Humana's LI NET operation as the central processor. That is why the Humana name can appear even when Humana is not your drug plan.

Basic Part D, supplemental coverage, and the Bridge side by side

Behind the scenes, participating manufacturers provide Bridge medication at a $245 net price per monthly supply and you pay $50. Neither number touches your Part D deductible or your Part D out-of-pocket total.

Who qualifies for the Medicare GLP-1 Bridge?

First, your plan type has to be eligible: a standalone Part D plan, or a Medicare Advantage coordinated-care plan with drug coverage — HMO, HMO-POS, or local or regional PPO. Special Needs Plans, employer/union group waiver plans, and LI NET can qualify too. Some other Medicare plan types do not qualify unless you also have a standalone PDP.

Then one of these three, straight from Medicare's rules:

One more gate: CMS says type 2 diabetes, moderate-to-severe obstructive sleep apnea, or noncirrhotic MASH with moderate-to-advanced liver scarring makes you ineligible for the Bridge, even if your Part D plan will not cover a GLP-1 for that condition. Your prescriber has to decide whether a diagnosis still applies to you.

The kindest rule in the whole program: your BMI is measured from when you started GLP-1 treatment, not today. So if you've already lost weight and dropped below 35, your earlier dated BMI can still control. Medicare's own example describes someone who started in September 2024 at a BMI of 37 and is at 34 in July 2026; the prescriber should attest to the 37.

Ask your doctor to pull the dated measurement from your chart rather than guessing.

The trap: you can be turned down at both doors on the same day

This is the trap that can leave you paying cash even when you meet a medical criterion.

Medicare's language is exact. A prescription for a use that basic Part D could cover does not qualify for the Bridge, even when the Part D plan does not list that drug on its formulary.

Read that slowly. Your Humana plan can deny the formulary request. And the Bridge can reject the request because the stated purpose belongs in Part D. Two refusals. Opposite reasons. Same person, same BMI, same afternoon.

For the heart-risk overlap, CMS says the Bridge form does not require your doctor to attest that you do not have established cardiovascular disease. But if Wegovy is being prescribed to reduce major cardiovascular events, that request belongs in Part D. If it is being prescribed for weight management and the Bridge criteria are met, the Bridge lane may still apply.

So the purpose your doctor states decides your path. Not a random diagnosis code. Not a trick. The real treatment purpose.

That's a five-minute conversation that can save you five weeks.

Nine drugs that can quietly close the Bridge door

Here is a rule buried in CMS guidance that many patients will not expect. If Medicare Part D paid for one of these GLP-1 drugs in 2026, the Bridge is closed to you for the rest of 2026. CMS checks its own Part D claims data.

Five of those nine are diabetes drugs. So a Humana member who filled Trulicity for diabetes in March can be locked out of the weight-management Bridge in August. It's not intuitive, and CMS says the pharmacy gets the ineligibility message and can pass it along. If you want to ask directly, call 1-800-MEDICARE.

There's a related trap for retiree plans: if your Group Medicare plan added supplemental weight-loss coverage and Part D paid a 2026 GLP-1 claim through that plan, you're also locked out of the Bridge for the rest of 2026. CMS says that person should continue to seek treatment through the Part D plan.

And one open question, as of August 8, 2026: Medicare has not decided the lookback period it will use for 2027. So January may or may not reopen the door. Nobody knows yet, including us.

The exact Wegovy products the Bridge pays for

Hand this to your pharmacist. Medicare publishes the specific product codes, and only these Wegovy NDCs are currently listed:

Also covered: all currently listed forms of Foundayo, and only the Zepbound KwikPen. Zepbound single-dose vials and single-dose pens are not in the Bridge.

The pharmacy bills the Bridge under BIN 028918 and PCN MEDDGLP1BR. If your pharmacist says they have never heard of the program, those two numbers are what they need. The pharmacy help desk is 844-673-0910. Prescribers can call 855-273-0102, Monday through Friday, 8 a.m. to 7 p.m. Eastern.

If Humana pushes you toward the Bridge instead of doing its Part D job

Worth knowing you have a lever here. Medicare told plans that they must keep following their normal coverage-determination and formulary-exception processes for Part D-coverable uses. The Bridge does not erase Medicare appeal rights for a Part D request, and CMS says it will watch for plans trying to shift those decisions into the Bridge.

If you have a genuine heart-risk or MASH prescription and Humana tells you to use the weight-management Bridge instead, ask for a real Part D coverage decision. Those are different uses with different rights.

How long does a Humana Wegovy prior authorization take?

For a Humana Medicare Part D coverage decision, Medicare sets the clock: generally 72 hours for a standard request and 24 hours for an urgent one. The detail that matters most is when the clock starts. For an exception request, it does not start until Humana receives your doctor's supporting statement — so a request sitting incomplete is not running at all.

That last sentence is the most useful timing fact on this page.

People call on day ten and hear "we don't have everything we need." Ten days of nothing. The clock never started.

What each system's clock looks like

Track three timestamps, not one

Most people track one date: "the day my doctor sent it." That's why the timeline feels like a black hole. Write down all three:

1. When the pharmacy ran the claim — and, for the Bridge, whether it was sent to the Bridge processor rather than Part D
2. When your doctor's office actually submitted the request — ask for a confirmation or reference number
3. When Humana, CMS's Bridge processor, the state, or Express Scripts says it received a complete request

If any of those three is missing, you know where the problem is. That's a much better phone call than "has it been approved yet?"

About asking for the fast version

An expedited Medicare request is for when waiting could seriously harm your health, and your doctor makes that call. Cost, inconvenience, or an upcoming trip do not meet the standard. Ask your prescriber whether it applies. Don't ask for it just to jump a line — it won't change the answer, only the speed.

What we won't tell you

You'll see pages claiming "Humana takes 7 to 14 business days" or "the form takes a doctor 12 to 18 minutes." Those numbers aren't sourced to anything. Medicare publishes real clocks. We use those.

Where does my doctor actually send the Humana Wegovy prior authorization?

It depends on the system. For Humana Medicare, Humana names CoverMyMeds as its preferred electronic prior-authorization channel, with Humana Clinical Pharmacy Review as the phone and fax route. For the Medicare GLP-1 Bridge, the pharmacy sends the first claim directly to the national Bridge processor, then the prescriber submits electronically or by fax. For Medicaid it is your state's form, and for TRICARE it is Express Scripts.

Sending the right form to the wrong place can cost you weeks.

One caution: if you search for a Humana Military prior authorization phone number, you will find a provider line for medical services. Wegovy pharmacy requests go to Express Scripts.

Why Bridge requests fail with "patient not found"

This one is pure sequence, and it's fixable in a day.

The Bridge is backwards from a normal prior authorization. The pharmacy has to send a claim to the Bridge processor first. A Part D denial is not required. That first Bridge claim creates the record. Only then can the prior authorization be matched to the patient.

A doctor who files first, before a pharmacy sends a Bridge claim, can get "patient not found" with the right patient and the right drug. Nothing is wrong with the paperwork. The order is wrong.

If that happens: have the pharmacy send the claim directly to the Bridge using the BIN and PCN above, confirm the Bridge response, then have the office resubmit.

Can I fill out the form myself?

No, not the clinical part. The attestation and medical information must come from your prescriber.

But that doesn't leave you powerless. You can confirm your benefits, get the exact form name, get the reference number, track the three timestamps, and hand your doctor's office a complete list of what the reviewer wants. Front-desk staff are juggling dozens of these. Showing up with the dates and numbers already gathered can help them file the right request faster.

Five questions to ask when you call Humana

Have your card out. Write down the answers and the reference number.

1. "Is Wegovy covered under my exact plan, and for which use?"
2. "Is this a prior authorization, a formulary exception, a supplemental benefit, or an excluded benefit?"
3. "Which company or department processes this request?"
4. "Which form or electronic channel should my prescriber use?"
5. "If my prescription is for weight management and I have Medicare drug coverage, does my plan have a supplemental weight-drug benefit, or should the pharmacy send the claim to the Medicare GLP-1 Bridge?"

That fifth question can save weeks.

Why did Humana deny my Wegovy prior authorization?

The reason on the letter decides the fix, and the reasons are not equally fixable. "Missing information" is usually solved by supplying what the reviewer named. "Benefit excluded" means the request hit a benefit that does not cover that use. "Wrong processor" means the request went to the wrong system entirely. Read the exact sentence before you spend two weeks on an appeal.

Five different things get called "denied." They need five different responses.

Read one sentence, not the whole letter

Find these six things and write them down:

• Who decided — Humana, Medicare's Bridge processor, your state, or Express Scripts
• The date on the letter
• The drug and the use they reviewed
• The exact reason — the code or sentence
• What's missing, if anything
• Your deadline to respond, and whether the notice calls for an appeal, redetermination, reconsideration, or resubmission

That's your whole action plan. Everything else in the envelope is boilerplate.

One privacy note: don't upload your denial letter to a general web form anywhere. Those letters carry your member number and other identifiers. Pick the denial category instead. You do not need to upload the letter to use the checklist below.

### 👉 Build the right denial packet Use our free six-point medical-necessity checklist to match the denial reason to the chart notes, records, and prescriber statement your packet needs. See the GLP-1 medical-necessity checklist → Free. No member ID required.

How do I appeal a Humana Wegovy denial?

"Appeal" does not describe every next step. A Humana Medicare Part D denial can go to a redetermination, which generally must be requested within 65 days. The Medicare GLP-1 Bridge has no formal appeal — your doctor resubmits only when information is corrected, added, or updated. Medicaid and TRICARE use their own notice-driven processes.

Humana Medicare: redetermination

This is the real Medicare Part D appeal, and it can help when the problem is documentation, coding, formulary status, or how a criterion was applied.

• Deadline: generally 65 calendar days from the denial notice. Not 60 — Medicare's current guidance says 65.
• Standard decision: generally 7 days.
• Expedited decision: generally 72 hours.
• Include the denial notice, the exact issue, and your doctor's statement pointing to the specific chart evidence.

There are more levels after that if you need them.

The Bridge: no formal appeal exists

Medicare says there is no appeals process under the Medicare GLP-1 Bridge. The named remedy is resubmission when information was wrong, incomplete, updated, or added.

We're not going to soften that. It's the single worst feature of the program.

But a fixable paperwork error does not have to become a 65-day Part D appeal. A wrong BMI date, a missing qualifying condition, or the "patient not found" sequence problem can be corrected and resubmitted. That does not make every Bridge denial winnable. It means a bad submission can be fixed without pretending the Bridge has an appeal right it does not have.

If the request belongs in Part D because the stated use is heart-risk reduction or MASH, that route has Medicare coverage-decision and appeal rights.

Humana Medicaid

Your denial notice controls the deadline, the appeal address, and whether you can keep getting the medication while you appeal. In many states, asking for continued benefits has a short window. Read the notice the day it arrives, not the week after.

TRICARE

Express Scripts handles the first pharmacy review. The current form says active-duty requests must still go to the TRICARE pharmacy contractor first, even when the form would not approve coverage, before reconsideration at the appropriate military treatment facility. Other TRICARE members should follow the denial notice and current formulary process.

Appeal or just resubmit?

What if I have Humana Healthy Horizons Medicaid?

Then your state writes the Wegovy rules, not one national Humana office. Humana's current member-facing Healthy Horizons programs are in Florida, Indiana, Kentucky, Louisiana, Ohio, Oklahoma, South Carolina, and Virginia. The criteria, forms, cost sharing, and appeal rights come from each state program.

Two of these states publish enough for us to show you exactly how far apart they can be.

Virginia: Humana's own form, and the bar is high

We opened Humana's Healthy Horizons in Virginia weight-loss management request form — document 766401VA0625, dated June 2025. It's Humana's own document, and it is specific.

For GLP-1s prescribed for weight management, the Wegovy path requires:

• BMI over 40 with no listed risk factor, or over 37 with dyslipidemia, high blood pressure, or type 2 diabetes
• Tried and failed a non-GLP-1 weight-loss drug first, or the form's intolerance exception applies
• Not taking another GLP-1 at the same time
• Nutritional counseling participation
• A physical activity program, unless medically contraindicated
• A written commitment to continue
• Current, accurate height and weight
• A copy of the previous weight-loss plan, with a summary of prior diet and exercise attempts
• The form's clinical exclusions, including eating-disorder history, acute pancreatitis, suicidal ideation, and personal or family history of medullary thyroid cancer or MEN 2
• The doctor must attest that the obesity is "disabling and life threatening"

That suicidal-ideation item is a requirement on the Virginia Medicaid form. It should not be confused with the current FDA Wegovy label: FDA asked manufacturers to remove the GLP-1 suicidal-behavior and ideation warning in 2026 after its review found no increased risk.

Approval is 6 months at a time. Renewal needs 5% loss compared with the most recent authorization, and stops once BMI falls below 25.

Notice something odd in that same document: its general criteria section says BMI 30, or 27 with one weight-related condition. Then the GLP-1 section sets a completely different bar 10 to 13 points higher. Two thresholds, one form. The higher GLP-1 thresholds apply to Wegovy.

Louisiana: no weight-only path, but real heart and liver paths

Louisiana's current Medicaid Wegovy criteria have no weight-management-only pathway. The published paths are established cardiovascular disease and MASH.

The cardiovascular path is not a checkbox. It is a full audit:

• You must be 45 or older. The FDA heart-risk indication has no 45-year floor; 45 comes from Louisiana's coverage criteria.
• BMI 27 to under 35. At 35 or above, a bariatric-surgery evaluation or referral also has to be documented. A higher BMI means more paperwork, not less.
• Established cardiovascular disease and optimized cardiovascular care must be documented under the path that applies.
• You must not have type 1 or type 2 diabetes.
• No other GLP-1 at the same time.
• You have to sign something. Louisiana requires a patient-signed Semaglutide (Wegovy) Treatment Agreement with the request.

Louisiana also publishes a MASH path. Because the current FDA MASH indication belongs to Wegovy injection, a MASH request should use the injection rather than the tablet.

Initial approval is 6 months. More than 5% loss can support 6 more months. Under 5% with written justification can support 3 months. Still under 5% after that 3-month window? The criteria say not to approve continuation.

If your state isn't Virginia or Louisiana

We read those two. We're not going to guess at the other six, because these documents genuinely do not match each other.

Call the number on your plan card and ask for exactly two things: the current preferred drug list and the current Wegovy or weight-management prior authorization criteria. Then ask which version is in effect and what date it took effect. Your state Medicaid pharmacy site should publish the controlling documents.

What if my Humana card says Humana Military or TRICARE?

Then Humana is not your pharmacy decision-maker. Humana Military administers TRICARE East, but Express Scripts runs the TRICARE pharmacy program and the Department of Defense sets the criteria. Wegovy can be covered for weight management with an approved prior authorization on eligible TRICARE Prime, Select, and qualifying premium-based coverage.

The weird part is simple: the Humana name is on the medical plan, but the Wegovy form goes somewhere else.

What you need to know:

• TRICARE says weight-loss drugs can be covered for eligible members in TRICARE Prime, TRICARE Select, or qualifying premium-based plans, including TRICARE Young Adult, TRICARE Reserve Select, TRICARE Retired Reserve, and the Continued Health Care Benefit Program.
• As of August 31, 2025, coverage ended for TRICARE For Life and other beneficiaries who are not enrolled in an eligible Prime, Select, or qualifying premium-based plan. Those members generally pay the full cost for a weight-loss drug used to treat obesity.
• The current Express Scripts Wegovy/Zepbound form lists an initial approval of 12 months, followed by annual renewal.
• For adult weight management, the form starts at BMI 30, or BMI 27 to 29 with a listed weight-related condition.
• The form requires at least 6 months of documented behavior change and diet restriction and asks for continued participation.
• The adult path generally asks for a 3-month trial of a generic weight-loss stimulant with failure to lose 5% of body weight, unless the form's contraindication, interaction, or adverse-reaction exception applies.
• The form says non-FDA-approved uses are not approved and specifically names diabetes mellitus. Wegovy is not a diabetes treatment request on TRICARE.
• For active-duty service members, the request still goes to Express Scripts first even when the form would not approve it; reconsideration can then occur at the appropriate military treatment facility under service rules.

Use the current TRICARE Formulary Search Tool or the current Express Scripts form every time. The form we verified lists 866-684-4488 by phone, 866-684-4477 by fax, and [email protected] by email.

If you have TRICARE and Medicare Part D, compare the TRICARE rule with the Medicare Bridge rule before anyone sends paperwork. The correct payer depends on your TRICARE eligibility, Part D plan type, prior 2026 GLP-1 claims, and stated treatment purpose.

What will Wegovy cost after Humana approves it?

It depends which door you came through. The Medicare GLP-1 Bridge is a flat $50 per monthly supply. A Humana Part D approval for heart risk or MASH uses your plan's tier and cost sharing until covered basic Part D spending reaches the 2026 out-of-pocket cap of $2,100. A supplemental Medicare benefit, Medicaid, and TRICARE each use plan-specific cost sharing. If no insurance door opens, Novo Nordisk's current self-pay prices run from $149 to $399 per month by form and dose, with no separate membership fee.

Here's our honest ranking. We're going to put the option we get paid on last, because for most people reading this, it should be the last paid layer you add.

NovoCare's exact self-pay prices verified August 8, 2026

A valid prescription and program eligibility are required. Novo Nordisk says it can change or cancel the offers. Check the price again on the day you fill.

Two cost traps on the Bridge. That $50 does not count toward your Part D deductible or out-of-pocket cap, and Extra Help does not lower it. Coupons and discount programs cannot be applied to the Bridge copay. So it is cheaper today, but it does not move you closer to the Part D cap.

One damaging admission, and then the honest pivot

Our provider guidelines say to lead with Ro on brand-name insurance questions. On this page, we can't do that cleanly, and you deserve to know why.

Ro's government-plan lane is mainly cash-pay. Ro says people with Medicare, Medicare Supplement, or TRICARE may be eligible for certain cash-pay options. It says FEHB members can use its insurance concierge. It also says Medicaid members and some other government-plan members are not eligible for treatment on Ro. So if your problem is getting Humana, the Bridge, Medicaid, or TRICARE to approve Wegovy, Ro does not replace that process. Scroll back up to the routing and appeal sections instead.

But here's what that limitation buys you. A cash-pay prescription sits outside the insurance prior-authorization system. There is no formulary exception or Humana approval clock attached to the cash-pay purchase. Ro says cash-pay prescriptions sent to Ro or a partner pharmacy generally ship within a week once prescribed, though fulfillment can vary. For the person who has genuinely run out of insurance doors, that can be a real next move instead of another month in the same fax queue.

### 👉 If you've run out of insurance doors Ro is a cash-pay path to FDA-approved GLP-1 treatment, if prescribed. Get started for $39, then pay as low as $74/month with a 12-month plan prepaid annually; the month-to-month plan is currently $149. Medication cost is separate. See if you qualify and check current Ro pricing → (affiliate link) Confirm which product, dose, government-plan eligibility rule, and total medication price apply before you pay. No provider can promise Humana or the Bridge will approve anything, and this CTA is for a path that does not depend on that approval. If your real bottleneck is finding a clinician who can evaluate you and submit Bridge paperwork, Success by Sesame starts at $59/month with an annual subscription; medication is billed separately. Sesame has a Medicare Bridge-specific service page. (affiliate link)

And if you already have a prescriber, you may not need to pay for telehealth access at all. Novo Nordisk's own current self-pay program sells Wegovy for $149 to $399 depending on form, dose, and offer, with no telehealth membership fee. We make nothing when you do that. It may be the cheapest direct route after insurance options are exhausted, and we'd rather tell you than have you find out later.

Why we don't link compounded semaglutide on this page

Compounded semaglutide is not FDA-approved Wegovy. It is prepared by a compounding pharmacy rather than approved by FDA as a finished Wegovy product. A Wegovy prior authorization does not apply to it, and coverage or cash-pay rules are separate. Putting it inside a Humana Wegovy approval guide would blur two things that need to stay separate.

If you explore compounded semaglutide, do it on its own terms with clear sourcing and clear FDA-status language — not as though it were the product your Humana Wegovy request is asking to cover.

### The right GLP-1 provider isn't the same for everyone It depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred treatment path — injection or oral — and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with current pricing before you choose.

What other Humana members are running into

Public comment threads on Medicare help forums show the same confusions repeatedly: people who can't tell a prior authorization from a formulary exception, people unsure whether to call the plan or the pharmacy, and people denied over details they didn't know were criteria. This is useful for recognizing your own situation. It is not evidence about your coverage, and it says nothing about whether the medication works.

From one Medicare discussion thread, a member trying to sort out the same thing this page solves wrote:

"I got either a prior auth or an exception. I do not know which."

In a separate Kaiser Permanente Medicare Bridge thread, another member asked:

"Or, do I go to the pharmacy?"

Both are exactly the right questions and neither should be hard to answer. That's why the routing table is at the top of this page instead of buried at the bottom.

One caution about both. Somebody else's post tells you nothing about your plan, your state, your year, or your diagnosis. It only tells you what to ask, and it says nothing about how well the medication works for anyone.

What we actually verified

We separate three kinds of claims and source each one differently.

Provider-stated versus independently verified

Primary documents and official pages opened on August 8, 2026:

• CMS — Medicare GLP-1 Bridge
• CMS — Information for Bridge providers
• CMS — Information for Bridge pharmacies
• CMS — Information for Part D plans
• CMS — Excluded Drug Reference File FAQ
• Humana — 2026 Group Medicare Commonly Prescribed Medications List, Formulary 26800
• Humana — Virginia weight-loss management preauthorization form
• Louisiana Medicaid — Wegovy criteria
• Louisiana Medicaid — July 1, 2026 Preferred Drug List
• Humana — February 23, 2023 employer-commercial exit announcement
• TRICARE — weight-loss medication coverage
• Express Scripts — current TRICARE Wegovy/Zepbound PA form
• FDA — 2026 Wegovy injection and tablet supplement approval
• Wegovy current Prescribing Information
• NovoCare — Wegovy price guide
• Ro — current membership pricing
• Ro — government-plan eligibility and cash-pay limits
• Sesame — Medicare GLP-1 Bridge care page

What we could not confirm, and are telling you rather than papering over:

• We read one incomplete Humana summary formulary, not every Humana plan's full PDG. Your exact PDG and EOC are the final word.
• We could not retrieve one national public Humana clinical policy that gives a complete Wegovy heart-risk and MASH checklist for every Medicare plan. The basic Part D comparison column stays thin instead of borrowing another plan's rule.
• Supplemental weight-management benefits are plan-specific. We did not pretend one Group Medicare plan's extra benefit applies to another.
• We read Virginia and Louisiana Medicaid criteria in detail. We did not copy those rules onto the other six Humana Healthy Horizons states.
• CMS has not announced the 2027 Bridge lookback period.

What we did not claim:

• We did not say every Humana plan excludes Wegovy for weight management
• We did not say any appeal or resubmission will succeed
• We did not treat compounded semaglutide as FDA-approved Wegovy
• We did not use anyone's story as evidence that the medication works
• We did not publish an approval rate or "average Humana turnaround" that we could not trace to an authority

Frequently asked questions

Does Humana require prior authorization for Wegovy?

Usually, when your exact plan can cover Wegovy. But first identify the lane: basic Part D, a supplemental Medicare benefit, the Medicare GLP-1 Bridge, Medicaid, or TRICARE. The right request may be a PA, formulary exception, supplemental-benefit request, state request, or Bridge authorization.

What is the Humana Wegovy prior authorization phone number?

For Humana Medicare pharmacy review, Humana Clinical Pharmacy Review is 800-555-CLIN (2546), with fax 877-486-2621. Humana's own drug list names CoverMyMeds as its preferred electronic channel. For a plan-specific coverage question, call the number on the back of your member card.

For the Medicare GLP-1 Bridge, the prescriber line is 855-273-0102, the PA fax is 1-800-530-2404, and the pharmacy help desk is 844-673-0910.

How long does Humana take to approve Wegovy?

For a Humana Medicare Part D coverage decision, Medicare's clocks are generally 72 hours for a standard request and 24 hours for an urgent one. For an exception, the clock does not start until Humana has the prescriber's supporting statement. For the Bridge, the PA commonly reaches the prescriber 24 to 72 hours after the pharmacy sends the Bridge claim, and CMS says a decision is made within 72 hours after the PA is submitted.

Can I fill out the Wegovy prior authorization myself?

No, not the clinical portion. The prescriber must provide the medical information and sign or submit the attestation. You can gather the correct form, dates, measurements, prior-drug records, routing details, and reference numbers.

What BMI do I need for the Medicare GLP-1 Bridge?

BMI 35 or higher; BMI 30 or higher with one listed condition; or BMI 27 or higher with one listed condition. It is measured when you started GLP-1 treatment, not necessarily today. You must also be 18 or older, use an eligible Medicare Part D plan type, and meet the other Bridge rules.

I take Ozempic for diabetes. Can I still use the Bridge for Wegovy?

Not in the rest of 2026 if Part D paid that Ozempic claim in 2026. CMS checks for Part D-paid claims involving nine named GLP-1 drugs, including Ozempic, Mounjaro, Trulicity, Victoza, Rybelsus, Wegovy, Zepbound, Saxenda, and Foundayo. CMS has not yet announced the lookback period for 2027.

Why was my Wegovy prior authorization denied by Humana?

Read the exact reason. "Missing information" calls for the named records. "Criteria not met" calls for a line-by-line check against the correct rule. "Benefit excluded" means you should verify any supplemental benefit and then look at the other valid paths. "Wrong processor" means the request went to the wrong system.

Can I appeal a Medicare GLP-1 Bridge denial?

No formal Bridge appeal exists. Your prescriber can resubmit when information is corrected, added, or updated. If the request belongs in Part D because the stated use is heart-risk reduction or MASH, the Part D route has Medicare coverage-decision and appeal rights.

Can I appeal a Humana Medicare Wegovy denial?

Yes, when it is a Part D coverage denial. The first appeal is generally called a redetermination, and you usually have 65 calendar days from the notice. Standard redeterminations are generally decided within 7 days; expedited ones within 72 hours.

Does Humana Healthy Horizons Medicaid cover Wegovy?

It depends on your state and the approved use. Humana's current Healthy Horizons member programs are in Florida, Indiana, Kentucky, Louisiana, Ohio, Oklahoma, South Carolina, and Virginia. Virginia publishes a weight-management path with BMI over 40, or over 37 with a listed risk factor, plus a prior-drug requirement. Louisiana's current criteria publish cardiovascular and MASH paths, not a weight-only path.

Does Humana Military cover Wegovy?

Humana Military administers TRICARE East, but Express Scripts runs the pharmacy benefit and the Department of Defense sets the criteria. Wegovy can be covered for weight management on eligible TRICARE Prime, Select, and qualifying premium-based coverage with an approved PA. The current form lists a 12-month initial approval.

Does the prior authorization differ for Wegovy tablets versus the pen?

It can. The Bridge currently lists both Wegovy injections and tablets. But the FDA-approved MASH use belongs to the injection, not the tablets. TRICARE's current form also treats age, use, and dosage form differently in parts of its decision tree. Confirm the exact product, strength, age, and purpose on the request.

Does my Wegovy refill need a new prior authorization?

It depends on the system. A Bridge PA can remain valid through December 31, 2027, and CMS says a new PA is not needed for refills unless you switch to another Bridge-covered GLP-1. But later Part D GLP-1 use or a move to an ineligible plan type can end Bridge eligibility. Virginia Medicaid approvals run 6 months. Louisiana's published renewals run 3 or 6 months depending on response. TRICARE's current form uses a 12-month initial approval followed by annual renewal.

Is the Medicare GLP-1 Bridge part of my Humana plan?

No. It is a federal demonstration outside Part D. Humana acts as the national processor, but having a Humana plan gives you no special advantage. CMS's clinical rules are national, and your Part D plan does not have to opt in.

Still not sure which GLP-1 program is right for you?

Five different paths. Multiple BMI thresholds. Basic and supplemental Medicare benefits that do not work the same way. Two federal doors that can reject the same person for opposite reasons. It's a lot, and it isn't your job to have memorized it.

Take our free 60-second matching quiz. Answer a few questions about your state, your insurance, your reason for taking Wegovy, and your budget, and we'll show you the treatment paths that actually fit — with current pricing and the exact questions to ask.

Take the free GLP-1 matching quiz →

No email gate. No commitment. A clear answer in plain English.

Related guides

• The Medicare GLP-1 Bridge: $50/Month Through December 2027
• GLP-1 Medical Necessity Letter: 6-Point Checklist
• Does Medicare Cover Wegovy for Weight Loss? 2026

How we made this guide

The RX Index Research Team built this page by opening the actual documents: Humana's 2026 Group Medicare medication summary, Humana's Virginia Medicaid weight-loss request form, Louisiana Medicaid's Wegovy criteria and July 2026 drug list, Medicare's Bridge rules for plans, pharmacies, providers, and beneficiaries, Humana's 2023 employer-commercial exit announcement, the current TRICARE coverage page and Express Scripts PA form, Wegovy's current prescribing information, and the current manufacturer and telehealth price pages. We separated the five approval paths because they do not use interchangeable rules, forms, or appeal rights. Sources were last checked August 8, 2026. Report a correction.

The RX Index is independent guidance for choosing your GLP-1 path. We don't take payment from Humana, Novo Nordisk, or any insurer. Some provider links are affiliate links and we may earn a commission at no extra cost to you — that never changes which option we recommend for which reader.

This guide is information, not medical or legal advice. Verify coverage details with Humana, CMS, your state program, or Express Scripts directly. Talk to your prescriber before starting, stopping, or changing any GLP-1 medication.